Main Article Content

Tairov Doston Rustamovich
Toirova Sevinch Farkhodovna


In our study, we studied a total of 50 patients with gout. Among them, patients with arterial hypertension were observed in 36 (72%) of the patients. In our study, patients were divided into 2 major groups according to the course of gout: recurrent patients in group I (n = 27) and patients with chronic disease in group II (n = 23). In both groups, the frequency and characteristics of cardiovascular lesions in patients were studied, as well as joint syndrome. A comparative analysis of arthritis syndrome was performed in patients with gout with arterial hypertension, ischemic heart disease, and chronic heart failure. The number of affected joints and the severity index of the disease in patients with arterial hypertension, coronary heart disease, and chronic heart failure with gout were also found to be higher than in patients without these diseases.

Article Details

How to Cite
Tairov Doston Rustamovich, & Toirova Sevinch Farkhodovna. (2022). CHARACTERISTICS OF HEART VESSEL INJURY AND JOINT SYNDROME IN GOD DISEASE. Galaxy International Interdisciplinary Research Journal, 10(5), 559–564. Retrieved from


Nasonov E.L. 2015; Nasonov E.L., Karateev D.E., Satybaldyev A.M. and others., 2015;

Adams P.F. Current estimates from the National Health Interview Survey, 1996 / P.F. Adams, G.E. Hendershot, M.A. Marano // Vital Health Stat. - 1999.-Vol. 10.-p. 2000;

Saag K.G. Recent advances in the epidemiology of gout / K.G. Saag, T.R. Mikuls // Curr. Rheumatol. Rep. - 2005. - Vol. 7. - pp. 235-241;

Terkeltaub R.A. Clinical practice. Gout / R.A. Terkeltaub // N. Engl. J. Med. - 2003. - Vol. 349. - pp. 1647-1655.

Wallace K.L. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population / K.L. Wallace, A.A. Riedel, N. Joseph-Ridge // J. Rheumatol. -2004. -Vol. 31. -pp. 1582-1587.

Eliseev M.S. Clinical signs of metabolic syndrome in gout / M.S. Eliseev, V.G. Barskova, V.A. Nasonova // Clinical gerontology. - 2006. - Т. 12, № 2. - pp. 29-33

7.Toirov E.S., Toirov D.R., Solovev S.K. / Gout diagnosis and treatment - Tashkent-Uzbekistan-2020.

Toirov, Doston Rustamovich, and Doniyor Khasanovich Berdiyev. "CHARACTERISTICS OF CARDIOHEMODYNAMIC DISORDERS IN GOUT DISEASE." Scientific progress 2.3 (2021): 775-784.

Rustamovich T. D., Hasanovich B. D. COMORBID FACTORY OF HEART BLOOD VEHICLES AND METABOLIC SYNDROME IN PATIENTS // Archive of Conferences. - 2021. - Т. 14. - №. 1. - p. 18-24.https: //

Toirov D. R., Maxmudova X. D. CARDIOVASCULAR DAMAGE IN PATIENTS WITH GOUT DISEASE // Scientific progress. - 2021. - Т. 2. - №. 2. - p. 242-249.https: //

Yarmukhamedova, S., Nazarov, F., Mahmudova, X., Vafoeva, N., Bekmuradova, M., Gaffarov, X., ... & Xusainova, M. (2020). Features of diastolic dysfunction of the right ventricle in patients with hypertonic disease. Journal of Advanced Medical and Dental Sciences Research, 8(9),. -p.74-77. http: //

Toirov D. R., Toirov E. S. Metabolic syndrome in gout: relationship with functional disorders of the kidneys // Questions of science and education. – 2019. – no. 28 (77). – p. 46-51.

Bekmuradova M. S., Gafforov Kh. Kh., Yarmatov S. T. Significance of the determination of brain natriuretic peptide in the process of diagnosing chronic heart failure // Achievements of science and education. – 2020. – no. 4 (58).

Bekmuradova M. S., Makhmudova Kh. D., Nazarov F. Yu. Diagnostic significance of brain natriuretic peptide in the detection of chronic heart failure //Scientific progress. - 2021. - Vol. 2. - No. 1. - pp. 810-814.

Yarmukhamedova S. Kh., Bekmuradova M. S., Nazarov F. Yu. Diagnostic value of natriuretic peptide in identifying patients with asymptomatic systolic or diastolic dysfunction // Achievements of science and education. – 2020. – no. 8 (62). – pp. 84-88.